Kanada - Französisch - Health Canada

angita pharma inc. - rispéridone - comprimé - 4mg - rispéridone 4mg - atypical antipsychotics

Kanada - Französisch - Health Canada

mylan pharmaceuticals ulc - rispéridone - comprimé - 4mg - rispéridone 4mg - atypical antipsychotics

Kanada - Französisch - Health Canada

mylan pharmaceuticals ulc - rispéridone - comprimé (à désintégration orale) - 4mg - rispéridone 4mg - atypical antipsychotics

Kanada - Englisch - Health Canada

mylan pharmaceuticals ulc - risperidone - tablet (orally disintegrating) - 4mg - risperidone 4mg - atypical antipsychotics

Kanada - Französisch - Health Canada

sun pharma canada inc - rispéridone - comprimé - 4mg - rispéridone 4mg - atypical antipsychotics

Kanada - Englisch - Health Canada

ranbaxy pharmaceuticals canada inc. - risperidone - tablet - 4mg - risperidone 4mg - atypical antipsychotics

Kanada - Englisch - Health Canada

dominion pharmacal - risperidone (risperidone tartrate) - solution - 1mg - risperidone (risperidone tartrate) 1mg - atypical antipsychotics

Kanada - Französisch - Health Canada

laboratoire riva inc. - rispéridone - comprimé - 4mg - rispéridone 4mg - atypical antipsychotics

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - risperidone, quantity: 4 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; pregelatinised maize starch; lactose monohydrate; sodium lauryl sulfate; purified talc; magnesium stearate; titanium dioxide; hypromellose; propylene glycol; iron oxide red - ? risperidone tablets are indicated for the treatment of schizophrenia and related psychoses. ? risperidone tablets are indicated for the short-term treatment of acute mania associated with bipolar 1 disorder (see section 4.2 dose and method of administration ? bipolar mania)). ? risperidone tablets are also indicated for the treatment (up to 12 weeks) of psychotic symptoms, or persistent agitation or aggression unresponsive to non-pharmacological approaches in patients with moderate to severe dementia of the alzheimer type. (see section 4.2 dose and method of administration: behavioural disturbances in dementia) ? risperidone tablets are indicated in the treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub average intellectual functioning or mental retardation in whom destructive behaviours (eg. aggression, impulsivity and self-injurious behaviours) are prominent. (see section 5.1 pharmacodynamic properties ? clinical trials for maintenance data). ? risperidone tablets are indicated for the treatment of behavioural disorders associated with autism in children and adolescents (see section 5.1 pharmacodynamic properties ? clinical trials)

Malta - Englisch - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - risperidone - film-coated tablet - risperidone 4 mg - psycholeptics